ATE52508T1 - 4-hydroxy-3-chinolincarbonsaeurederivate, 2substituiert durch eine stickstoff enthaltende gruppe, ihre herstellung, ihre verwendung als arzneimittel, diese enthaltende zubereitungen und zwischenprodukte. - Google Patents

4-hydroxy-3-chinolincarbonsaeurederivate, 2substituiert durch eine stickstoff enthaltende gruppe, ihre herstellung, ihre verwendung als arzneimittel, diese enthaltende zubereitungen und zwischenprodukte.

Info

Publication number
ATE52508T1
ATE52508T1 AT85401233T AT85401233T ATE52508T1 AT E52508 T1 ATE52508 T1 AT E52508T1 AT 85401233 T AT85401233 T AT 85401233T AT 85401233 T AT85401233 T AT 85401233T AT E52508 T1 ATE52508 T1 AT E52508T1
Authority
AT
Austria
Prior art keywords
group
carbon atoms
alkyl
hydroxy
hydrogen
Prior art date
Application number
AT85401233T
Other languages
English (en)
Inventor
Francois Clemence
Martret Odile Le
Francoise Delevallee
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of ATE52508T1 publication Critical patent/ATE52508T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT85401233T 1984-06-25 1985-06-20 4-hydroxy-3-chinolincarbonsaeurederivate, 2substituiert durch eine stickstoff enthaltende gruppe, ihre herstellung, ihre verwendung als arzneimittel, diese enthaltende zubereitungen und zwischenprodukte. ATE52508T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8409960A FR2566405B1 (fr) 1984-06-25 1984-06-25 Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
EP85401233A EP0169755B1 (de) 1984-06-25 1985-06-20 4-Hydroxy-3-chinolincarbonsäurederivate, 2-substituiert durch eine Stickstoff enthaltende Gruppe, ihre Herstellung, ihre Verwendung als Arzneimittel, diese enthaltende Zubereitungen und Zwischenprodukte

Publications (1)

Publication Number Publication Date
ATE52508T1 true ATE52508T1 (de) 1990-05-15

Family

ID=9305386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85401233T ATE52508T1 (de) 1984-06-25 1985-06-20 4-hydroxy-3-chinolincarbonsaeurederivate, 2substituiert durch eine stickstoff enthaltende gruppe, ihre herstellung, ihre verwendung als arzneimittel, diese enthaltende zubereitungen und zwischenprodukte.

Country Status (10)

Country Link
US (1) US4636512A (de)
EP (1) EP0169755B1 (de)
JP (1) JPH064628B2 (de)
AT (1) ATE52508T1 (de)
AU (1) AU578479B2 (de)
CA (1) CA1251446A (de)
DE (1) DE3577558D1 (de)
ES (1) ES8608517A1 (de)
FR (1) FR2566405B1 (de)
ZA (1) ZA854376B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585356B1 (fr) * 1985-07-25 1987-10-23 Roussel Uclaf Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant
FR2572404B2 (fr) * 1984-10-30 1987-12-11 Roussel Uclaf Nouveaux derives de l'acide 4-oh-3-quinoleine carboxylique substitues en 2, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
CN102267984B (zh) * 2010-06-04 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 4-羟基喹啉-3-酰胺衍生物及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534031A (en) * 1965-05-17 1970-10-13 American Home Prod Acetoxymethyl acetamides and acetamidoacetamides and their preparation
FR2281761A1 (fr) * 1974-08-13 1976-03-12 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2443467A1 (fr) * 1978-12-08 1980-07-04 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
DE3000309A1 (de) * 1980-01-05 1981-07-09 Basf Ag, 6700 Ludwigshafen 4h-3,1-benzoxazinderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
HU190796B (en) * 1981-06-12 1986-11-28 Roussel Uclaf,Fr Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2530633A1 (fr) * 1982-06-03 1984-01-27 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
FR2532939A1 (fr) * 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
CA1263651A (en) * 1984-07-09 1989-12-05 Ciba-Geigy Ag Certain ring-fused pyrazolo ¬3,4-d|-pyridin-3-one derivatives

Also Published As

Publication number Publication date
EP0169755B1 (de) 1990-05-09
AU578479B2 (en) 1988-10-27
JPH064628B2 (ja) 1994-01-19
US4636512A (en) 1987-01-13
ZA854376B (en) 1986-08-27
JPS6115876A (ja) 1986-01-23
EP0169755A2 (de) 1986-01-29
FR2566405B1 (fr) 1986-09-26
ES544420A0 (es) 1986-06-16
ES8608517A1 (es) 1986-06-16
FR2566405A1 (fr) 1985-12-27
EP0169755A3 (en) 1986-04-09
DE3577558D1 (de) 1990-06-13
CA1251446A (fr) 1989-03-21
AU4411785A (en) 1986-01-02

Similar Documents

Publication Publication Date Title
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
DE3762860D1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
DE3577558D1 (de) 4-hydroxy-3-chinolincarbonsaeurederivate, 2-substituiert durch eine stickstoff enthaltende gruppe, ihre herstellung, ihre verwendung als arzneimittel, diese enthaltende zubereitungen und zwischenprodukte.
IE780145L (en) Meta-sulphonamido-benzamides
KR880001677A (ko) β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체
ATE194338T1 (de) Diphenylthiazolderivate mit antiinflammatorischer aktivität
NO153138C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidobenzoazepinderivater.
DE69130266D1 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
NO955112L (no) Fremgangsmåte for fremstilling av oksazolidinkarboksylsyre samt anvendelse derav for fremstiling av terapeutisk aktive taxoider
DE3574592D1 (de) Esterderivate von 2-alpha-hydroxy-substituierter 4-hydroxy-3-chinolincarbonsaeure, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
DE59308970D1 (de) Oxazolidin Verbindungen und ihre Verwendung als Arzneimittel
ATE134607T1 (de) Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung
AR241434A1 (es) Procedimiento para la preparacion de 3-(piperidinil)-1h-indazoles.
DE69419083D1 (de) Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE68903893D1 (de) 20,21-dinoreburnamenin-derivate, substituiert in position 15 durch eine aminogruppe und deren salze, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen.
FI882667A7 (fi) Foerfarande foer framstaellning av antibakteriska vid 7-staellningen substituerade 1-cyklopropyl-6-fluor -1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyror.
ES8200112A1 (es) Un procedimiento para la preparacion de un derivado del aci do clavulanico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee